Shares of Macy's jumped 6.9% to $23.31 after the retailer posted its strongest first-quarter comparable sales growth in four years and raised its full-year outlook — a rare "beat and raise" for a legacy department store navigating tariff headwinds and cautious consumers.

• An Earnings Beat That Wasn't Even Close

Analysts had expected first-quarter revenue of $4.61 billion and adjusted earnings per share of three cents.

Macy's delivered $4.68 billion in net sales and net income of $63 million, or 23 cents per diluted share, compared with $38 million a year earlier.

Adjusted EPS came in at $0.13, still well above estimates. That profit nearly doubling year-over-year signals the turnaround is producing real bottom-line results, not just foot traffic.

• Bloomingdale's Is Carrying the Load

Bloomingdale's achieved a 10.2% increase in comparable sales, marking its highest first quarter sales in its 154-year history.

CEO Tony Spring credited buzzy brands, a "fun factor," and the recent bankruptcy of rival Saks Fifth Avenue.

The Macy's namesake banner saw a 1.6% comparable sales increase, and Bluemercury added a 6.4% gain. The luxury and beauty brands are punching above their weight; the core Macy's stores, where most revenue sits, still grew modestly.

• The Guidance Raise Bakes In Tariff Pain

Macy's lifted full-year net sales guidance to $21.5–$21.75 billion, raised adjusted EPS to $2.00–$2.20 from $1.90–$2.10, and now expects comparable sales to grow 0.5%–1.2% versus a prior range of down 0.5% to up 0.5%. Crucially, guidance assumes the first half of the year will have a larger tariff impact than the second half and does not include the potential receipt of tariff refunds.

Gross margin dipped 30 basis points to 38.9%, though excluding tariff impact, it was flat. That means management is absorbing import costs now and still raising the bar.

• Cash Returns Signal Confidence, but Insiders Are Selling

Macy's returned $50 million via dividends and repurchased 2.6 million shares for $50 million in Q1, with roughly $1.1 billion remaining on its buyback authorization.

The balance sheet shows $1.3 billion in cash, $2 billion in credit availability, and no major debt maturities until 2030. Yet insiders sold $2.9 million in stock over the last three months — a disconnect worth watching. At roughly 11× midpoint EPS, the stock remains cheap, but investors must decide whether five consecutive quarters of beats mark a genuine inflection or a temporary bump from tax refunds and a weakened competitor.